Relay Therapeutics (RLAY) Stock Price, Quote, News & History | Benzinga

Relay Therapeutics Inc (RLAY) Stock Price, Quote, News & History

RLAYNASDAQ

Trade with Public

Trade with Public

$14.13

0.080.57%

Last update: Jun 1, 3:04 PM

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$14.01

Close

-

Volume / Avg.

1.37M / 3.61M

Day Range

$13.30 - $14.09

52 Wk Range

2.91 - 17.32

Market Cap

$3.08B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

57

Short Interest

15.41%

Days to Cover

10.29

Recent Relay Therapeutics Inc News

Relay Therapeutics Reports Early Success For Investigational Drug In Rare Vascular Disorders

Relay Therapeutics reported early Phase 2 data showing lesion reduction and symptom improvement with zovegalisib.

Vandana Singh

Relay Therapeutics' Cancer Drug Hits 11.1-Month Progression Free Survival - What Does This Means For Pretreated Breast Cancer Patients?

Relay Therapeutics shares rise after Phase 3 data show zovegalisib achieved 11.1-month PFS in metastatic breast cancer patients.

Vandana Singh

Relay Therapeutics Reports 'Robust Activity' For Precision Breast Cancer Drug

Relay Therapeutics shared interim data for zovegalisib at SABCS 2025, showing consistent efficacy in breast cancer patients.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-213.36M

Investing Cash Flow (TTM)

183.24M

Financing Cash Flow (TTM)

140.39M

Free Cash Flow (TTM)

-213.38M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

110.26M

Analyst Trends and Forecast

1

Feb

3

Mar

5

Apr

4

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.45B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

229.31

PB Ratio (TTM)

4.77

Earnings Yield % (TTM)

-11.10%

Earnings Yield % (FWD)

-11.81%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.95

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$204.59M

Debt to Equity

0.05

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$14.01

Close

-

Volume / Avg.

1.37M / 3.61M

Day Range

$13.30 - $14.09

52 Wk Range

2.91 - 17.32

Market Cap

$3.08B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

57

Short Interest

15.41%

Days to Cover

10.29

About

Sector

Health Care

Industry

Biotechnology

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and e...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Relay Therapeutics (RLAY) stock?

A

You can purchase shares of Relay Therapeutics (NASDAQ:RLAY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Relay Therapeutics (RLAY) competitors?

A

There are no as such competitors for Relay Therapeutics.

Q

What is the forecast, or price target, for Relay Therapeutics (RLAY) stock?

A

Relay Therapeutics has a consensus price target of $20.06.

Q

What is the current price for Relay Therapeutics (RLAY)?

A

The stock price for Relay Therapeutics (NASDAQ: RLAY) is $14.13 last updated June 1, 2026 at 3:04 PM EDT.

Q

Does Relay Therapeutics (RLAY) pay a dividend?

A

There are no upcoming dividends for Relay Therapeutics.

Q

When is Relay Therapeutics (NASDAQ:RLAY) reporting earnings?

A

Relay Therapeutics does not have any upcoming earnings scheduled.

Q

Is Relay Therapeutics (RLAY) going to split?

A

There is no upcoming split for Relay Therapeutics.

Q

What sector and industry does Relay Therapeutics (RLAY) operate in?

A

Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.